FDA — authorised 7 November 2018
- Application: NDA205920
- Marketing authorisation holder: ARMSTRONG PHARMS
- Status: approved
FDA authorised Primatene Mist on 7 November 2018
Yes. FDA authorised it on 7 November 2018.
ARMSTRONG PHARMS holds the US marketing authorisation.